Telomir Pharmaceuticals Inc (TELO)

Dec 19, 2025

How institutional buying supports Telomir Pharmaceuticals Inc. stock2025 Trading Recap & Verified Entry Point Signals - Улправда

Dec 19, 2025

Dec 19, 2025

Will Telomir Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

How Telomir Pharmaceuticals Inc. stock reacts to oil pricesJuly 2025 Pullbacks & Reliable Price Breakout Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Whale Trades: Is Telomir Pharmaceuticals Inc. stock a top momentum play2025 Market Outlook & Community Shared Stock Ideas - Улправда

Dec 19, 2025

Dec 18, 2025

Why analysts remain bullish on Telomir Pharmaceuticals Inc. stockTreasury Yields & Community Consensus Picks - Улправда

Dec 18, 2025

Dec 18, 2025

Can Telomir Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Trends & Capital Efficiency Focused Strategies - Улправда

Dec 18, 2025

Dec 18, 2025

Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 PostEarnings & Community Driven Trade Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development - ACCESS Newswire

Dec 18, 2025

Dec 18, 2025

Is Telomir Pharmaceuticals Inc. stock a top momentum playJuly 2025 Action & Accurate Buy Signal Alerts - Улправда

Dec 18, 2025

Dec 17, 2025

Telomir Pharmaceuticals Reports Positive IND-Enabling Study Results - TipRanks

Dec 17, 2025

Dec 17, 2025

TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - MSN

Dec 17, 2025

Dec 09, 2025

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells - USA Today

Dec 09, 2025

Dec 06, 2025

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Daily Commercial

Dec 06, 2025

Dec 05, 2025

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 05, 2025

Dec 05, 2025

Why Telomir Pharmaceuticals Inc. stock attracts high net worth investorsTrade Signal Summary & Free Community Supported Trade Ideas - Newser

Dec 05, 2025

Dec 04, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Up 2.3% – Still a Buy? - Defense World

Dec 04, 2025

Nov 28, 2025

Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - MSN

Nov 28, 2025

Nov 27, 2025

Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com

Nov 27, 2025

Nov 26, 2025

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data - MSN

Nov 26, 2025

Nov 25, 2025

Telomir reports PSA reduction in prostate cancer cells with lead drug - Investing.com Nigeria

Nov 25, 2025

Nov 25, 2025

Telomir reports PSA reduction in prostate cancer cells with lead drug By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 24, 2025

Telomir Pharmaceuticals Reports Promising Preclinical Data - TipRanks

Nov 24, 2025

Nov 24, 2025

[8-K] Telomir Pharmaceuticals, Inc. Reports Material Event | TELO SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 23, 2025

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells - Bluffton Today

Nov 23, 2025

Nov 21, 2025

Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025 - ts2.tech

Nov 21, 2025

Nov 21, 2025

Telomir stock surges after leukemia cell-killing data By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Telomir stock surges after leukemia cell-killing data - Investing.com UK

Nov 21, 2025

Nov 21, 2025

Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan

Nov 21, 2025

Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board By Investing.com - Investing.com Australia

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals Inc. Announces Resignation of Craig Eagle as Director, Effective on November 14, 2025 - MarketScreener

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy - TipRanks

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals, Inc. Announces Telomir-1 Kills Aggressive Human Leukemia Cells - marketscreener.com

Nov 20, 2025

Nov 20, 2025

How Telomir Pharmaceuticals Inc. stock performs after earnings2025 Market Overview & Precise Buy Zone Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Does Telomir Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 20, 2025